Benchmark Holdings PLC Notice of Q1 Results (8935P)
February 14 2023 - 6:45AM
UK Regulatory
TIDMBMK
RNS Number : 8935P
Benchmark Holdings PLC
14 February 2023
14 February 2023
Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")
Notice of Q1 Results
Presentation for analysts and institutional investors
Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK),
the aquaculture biotechnology business, will announce its Q1
results, for the three month period ended 31 December 2022, on
Tuesday 28 February 2023.
Presentation for analysts and investors at 9 am CET
Trond Williksen, Chief Executive Officer and Septima Maguire,
Chief Financial Officer will host an in-person presentation for
analysts and institutional investors on the day at 9.00 am CET/8.00
am UK time in Oslo, Norway. The presentation will take place at
Hotel Continental, Stortingsgata 24/26, 0117 Oslo.
A live webcast of the presentation is available for analysts and
investors to join remotely at the following link:
https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7
For further details, and to register your interest, please
contact benchmark@mhpgroup.com .
Equity Development webcast on Wednesday 1 March at 12 pm UK
time
Trond Williksen, Chief Executive Officer and Septima Maguire,
Chief Financial Officer will host a second webcast for retail
investors and wealth managers on Wednesday 1 March at 13.00 pm
CET/12.00 pm UK time. The webcast is open to all existing and
potential shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1results-presentation-1march2023
A recording of the presentation will be available after the
event on the Equity Development website .
Enquiries
For further information, please contact:
Benchmark Holdings plc Tel: 0114 240 9939
Trond Williksen, CEO
Septima Maguire, CFO
Ivonne Cantu, Investor Relations
Numis (Broker and NOMAD) Tel: 020 7260 1000
James Black, Freddie Barnfield, Duncan
Monteith
MHP Tel: 020 3128 8004
Katie Hunt, Reg Hoare, Veronica Farah benchmark@mhpgroup.com
Equity Development Tel: 020 7065 2692
Hannah Crowe
About Benchmark
Benchmark is a leading aquaculture biotechnology company.
Benchmark's mission is to enable aquaculture producers to improve
their sustainability and profitability.
We bring together biology and technology to develop innovative
products and solutions which improve yield, quality and animal
health and welfare for our customers. We do this by improving the
genetic make-up, health and nutrition of their stock - from
broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions,
including salmon eggs, live feed (Artemia), specialist diets and
probiotics and sea lice treatments. Find out more at
www.benchmarkplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORGPUCWPUPWGGC
(END) Dow Jones Newswires
February 14, 2023 06:45 ET (11:45 GMT)
Benchmark (LSE:BMK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Benchmark (LSE:BMK)
Historical Stock Chart
From Jul 2023 to Jul 2024